Learn, Analyse & Invest
only with

+91

Download Orca

To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Prism Medico and Pharmacy Ltd.

Prism Medico

₹ 0.00

0.00 (0.00)%

NSE

BSE

Trading

Small-cap - With a market cap of ₹18.29 Cr.

EX-Date	Purpose
27 04 2021	Audited Results Inter alia, to consider and approve To consider and discuss the following items: 1. To consider and approve the audited Financial Results for the year ended March 31, 2021. 2. To consider and approve the appointment of M/s. M R Chechi & Associates, Company Secretaries, Chandigarh as Secretarial Auditor of the company for F.Y. 2020-21. 3. To consider and approve the resignation of M/s. S Harpreet & Associates, Chartered Accountants, Punjab as Internal Auditor of the company for F.Y. 2020-21. 4. To consider and approve the appointment of M/s. N. Kumar & Company, Chartered Accountants, Punjab as Internal Auditor of the company for F.Y. 2020-21. 5. Any other matter with the permission of the Chair.
19 07 2021	Quarterly Results
20 08 2021	Inter alia, To consider and transact the following business: 1. To consider and approve the appointment of Mr. Ramandeep Singh (DIN: 07896086) as an Additional Independent Non-executive Director. 2. To consider and accept the resignation of Mr. Jimit Jintendra Trivedi (DIN: 08585697) from the directorship of the company. 3. To fix the Date, Time and Venue for convening 19th Annual General Meeting of the Members of the Company and approve the Draft Notice for the same. 4. To consider and approve the Draft Director’s Report for the F.Y. 2020-21 for the purpose of 19th Annual General Meeting. 5. To approve the Book-closure dates as per regulation 42 of the SEBI (LODR) Regulations, 2015 for the purpose of 19th Annual General Meeting of the Company. 6. To appoint the Scrutinizer for 19th Annual General Meeting. 7. Any other business with the permission of chair.
13 11 2021	Quarterly Results
30 12 2021	Inter alia, to consider and transact the following business: 1. To discuss and consider the appointment of Mr. Davender Singh as an Additional Director. 2. To discuss and consider the resignation of Mr. Sehejbir Singh Bhatia (DIN: 07986072) Director of the company. 3. To discuss and decide to recommend the shifting of the registered office of the company from State of Punjab to the State of Himachal Pradesh and also to amend the Memorandum of Association of the company subject to the approval of shareholders and compliance of SEBI Rules and Regulations. 4. To discuss and consider draft Notice of Postal Ballot, Agenda and Explanatory Statement pertaining to obtain approval of shareholders. 5. Any other business with the permission of chair.
01 02 2022	Quarterly Results
25 05 2022	Audited Results Inter alia, To consider and approve the appointment of M/s. M R Chechi & Associates, Company Secretaries, Chandigarh as Secretarial Auditors of the company for F.Y. 2022-23.
13 08 2022	Quarterly Results
05 09 2022	A.G.M.
14 11 2022	Quarterly Results
13 02 2023	Quarterly Results
30 05 2023	Audited Results
14 08 2023	Quarterly Results
04 09 2023	A.G.M. Inter-alia, to consider the following business: 1. To consider and approve the Director s Report along with all necessary annexures thereof, for the Financial Year ended March 31, 2023; 2. To consider and fix day, date, time for holding the 21st Annual General Meeting of the company and approve the notice of the same; 3. To consider and fix the date for closure of Register of Members and Share Transfer Books for the purpose of Annual General Meeting; 4. To appoint scrutinizer to conduct e-voting and poll process of 21st Annual General Meeting of the company; 5. To consider and recommend the re-appointment of M/s. Harjeet Parvesh and Company, Chartered Accountants as the statutory auditors of the company. 6. To consider and recommend the regularisation of appointment of Mr. Dinesh Kumar (DIN: 01149388) as an Independent Director of the company. 7. To consider and discuss any other routine matter or business of the company.
08 11 2023	Quarterly Results
13 02 2024	Quarterly Results
14 11 2024	Quarterly Results
14 02 2025	Quarterly Results
28 05 2025	Quarterly Results & Audited Results
14 08 2025	Quarterly Results
05 09 2025	Inter alia, to consider and approve:- 1. To consider and approve the Director s Report along with all necessary annexures thereof, for the Financial Year ended March 31, 2025; 2. To consider and fix day, date, time for holding the 23rd Annual General Meeting of the company and approve the notice of the same; 3. To consider and fix the date for closure of Register of Members and Share Transfer Books for the purpose of Annual General Meeting; 4. To appoint scrutinizer to conduct e-voting and poll process of 23rd Annual General Meeting of the company; 5. To consider and recommend the ratification of appointment of M/s. Garg Mendiratta and Associates, Chartered Accountants as the statutory auditors of the company in place of M/s. Harjeet Parvesh and Company, Chartered Accountants. 6. To consider and discuss any other routine matter or business of the company.
14 11 2025	Quarterly Results
13 02 2026	Quarterly Results
23 02 2026	Preferential Issue of shares & Inter alia, to consider the following businesses: 1. Consider and discuss alteration in the Articles of Association of the company subject to approval of shareholders. 2. Consider and discuss the proposal for fund raising by way of preferential issue/private placement of securities for cash, including determination of issue price subject to such regulatory/statutory approvals as may be required, including the approval of shareholders of the company. 3. Consider and discuss any other routine matter or business of the company.

News

No News data available